Tirzepatide is a once-weekly injectable dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed by Eli Lilly
Combining ketogenic diets with prescription GLP-1 agonists requires careful medical supervision due to increased risks of hypoglycemia and diabetic ketoacidosis, particularly in patients with diabetes taking insulin or sulfonylureas
If you are considering starting an injectable treatment pathway, our team at Batley Pharmacy is here to help
If you find thigh injections consistently more painful, you are not imagining it
Combining plant extracts, flavonoids, and essential micronutrients, it may help support key metabolic processes linked to appetite regulation and glucose balance
This prolonged transit time allows more water absorption from stool in the colon, resulting in harder, drier stools that are difficult to pass